Plurilock Security Inc (CVE:PLUR) (OTCQB:PLCKF) announced it has secured an order through IT service reseller GiaSpace to license Plurilock’s advanced continuous authentication software to a regional pharmaceutical manufacturer based in the southeastern US.
The company said the order includes deployment and support for Plurilock's high margin ADAPT and DEFEND products at the manufacturer's facilities to protect against credential sharing, unauthorized access, and phishing attacks.
“Plurilock's high margin software solutions work as a deterrence to attacks and form part of an in-depth defensive cybersecurity strategy, crucial to companies operating today,” Plurilock Security CEO Ian Paterson said in a statement.
READ: Plurilock Security wins two US government contracts worth $280,000
“With the deployment of Plurilock's authentication software, these organizations will be able to protect the workforce as well as other critical assets against cyberattacks,” Paterson added.
Plurilock noted its proprietary technology has the ability to recognize individuals and verify identities using behavioral biometric signatures, each generated by applying machine learning in the background to personal behavioral and input patterns, physical location, and other contextual data, as device users do their normal work, which will be beneficial for organizations in the pharmaceutical industry.
Victoria, British Columbia-based Plurilock Security is a cybersecurity company that provides multi-factor authentication (MFA) and true continuous authentication using AI-driven behavioral biometrics to confirm a user’s identity.
Unlike competing MFA solutions, Plurilock does not require users to complete lengthy login workflows using mobile messaging or code generators and, unlike competing continuous authentication solutions, the company provides true full-workday authentication in the background.
Contact Sean at sean@proactiveinvestors.com